CORAL GABLES, Fla.--(BUSINESS WIRE)--On Thursday, January 21, 2010, the Sabrina Cohen Foundation for Stem Cell Research (SCF) is hosting “Accelerate the Cure,” a fundraiser with Dr. Joshua Hare, Louis Lemberg Professor of Medicine, Director, Interdisciplinary Stem Cell Institute, University of Miami, Miller School of Medicine.
WHERE: THE COLLECTION, Jaguar Showroom, 200 Bird Road, Coral Gables
WHEN: Thursday, January 21, 2010 7 pm – 10 pm
“Accelerate the Cure” is another example of the Sabrina Cohen Foundation’s dedication to community outreach and education, furthering its mission to raise funds for targeted disease based stem cell research. Up to 150 guests will be attending the affair, including University of Miami faculty, distinguished business owners and South Florida residents.
Known for his work at Johns Hopkins University, Dr. Joshua Hare, a Cardiologist, is a world-renowned pioneer in the use of adult stem cells to repair heart damage. He currently has three ongoing FDA-approved clinical trials studying stem cell therapies for heart disease. Many researchers view heart disease, the number one killer of Americans, as the next “big frontier” in stem cell treatment. "We can now inject the cells exactly where we want to in the inside of the heart, and we can do it in multiple locations," noted Dr. Hare.
At the event, Dr. Hare will give an update about his latest research findings and introduce attendees to ISCI, a new state of the art stem cell research facility. Sign-up for private lab tours will follow the presentation. Guests will also have the opportunity to win a weekend loan on a Jaguar Xf through a raffle. Cocktails and Hors d’oeuvres will be served.
Based in Miami Beach, the Sabrina Cohen Foundation for Stem Cell Research, a 501c3 non-profit organization, was founded in 2006 by advocate and quadriplegic, Sabrina Cohen, who’s been living with a spinal cord injury since 1992. SCF is dedicated to becoming a leader in the fight against disease by funding top scientists in the country. Dr. Hare’s work is slated to be the next grant recipient of SCF.